Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BRENTUXIMAB VEDOTIN Cause Nervous system disorder? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Nervous system disorder have been filed in association with BRENTUXIMAB VEDOTIN (ADCETRIS). This represents 0.1% of all adverse event reports for BRENTUXIMAB VEDOTIN.

9
Reports of Nervous system disorder with BRENTUXIMAB VEDOTIN
0.1%
of all BRENTUXIMAB VEDOTIN reports
2
Deaths
1
Hospitalizations

How Dangerous Is Nervous system disorder From BRENTUXIMAB VEDOTIN?

Of the 9 reports, 2 (22.2%) resulted in death, 1 (11.1%) required hospitalization, and 1 (11.1%) were considered life-threatening.

Is Nervous system disorder Listed in the Official Label?

Yes, Nervous system disorder is listed as a known adverse reaction in the official FDA drug label for BRENTUXIMAB VEDOTIN.

What Other Side Effects Does BRENTUXIMAB VEDOTIN Cause?

Off label use (1,370) Neuropathy peripheral (695) Pyrexia (693) Febrile neutropenia (684) Death (602) Neutropenia (561) Hodgkin's disease (512) Nausea (392) Diarrhoea (385) Anaemia (374)

What Other Drugs Cause Nervous system disorder?

ADALIMUMAB (653) METHOTREXATE (489) CIPROFLOXACIN (449) ACETAMINOPHEN\PROPOXYPHENE (399) PROPOXYPHENE (399) RITUXIMAB (389) ETANERCEPT (361) CYCLOPHOSPHAMIDE (357) DEXAMETHASONE (346) LEVOFLOXACIN (323)

Which BRENTUXIMAB VEDOTIN Alternatives Have Lower Nervous system disorder Risk?

BRENTUXIMAB VEDOTIN vs BREO ELLIPTA BRENTUXIMAB VEDOTIN vs BREXANOLONE BRENTUXIMAB VEDOTIN vs BREXPIPRAZOLE BRENTUXIMAB VEDOTIN vs BREXUCABTAGENE AUTOLEUCEL BRENTUXIMAB VEDOTIN vs BRIGATINIB

Related Pages

BRENTUXIMAB VEDOTIN Full Profile All Nervous system disorder Reports All Drugs Causing Nervous system disorder BRENTUXIMAB VEDOTIN Demographics